1 Market Overview of Exosome Diagnostics and Therapeutics 1.1 Exosome Diagnostics and Therapeutics Market Overview 1.1.1 Exosome Diagnostics and Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Exosome Diagnostics and Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Exosome Diagnostics and Therapeutics Market Size by Region (2015-2026) 1.4 Global Exosome Diagnostics and Therapeutics Historic Market Size by Region (2015-2020) 1.5 Global Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) 1.6.1 North America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) 1.6.2 Europe Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) 1.6.4 Latin America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) 2 Exosome Diagnostics and Therapeutics Market Overview by Type 2.1 Global Exosome Diagnostics and Therapeutics Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Exosome Diagnostics and Therapeutics Historic Market Size by Type (2015-2020) 2.3 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2021-2026) 2.4 Instrument 2.5 Reagent 2.6 Software 3 Exosome Diagnostics and Therapeutics Market Overview by Application 3.1 Global Exosome Diagnostics and Therapeutics Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Exosome Diagnostics and Therapeutics Historic Market Size by Application (2015-2020) 3.3 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2021-2026) 3.4 Diagnostic 3.5 Therapeutic 4 Global Exosome Diagnostics and Therapeutics Competition Analysis by Players 4.1 Global Exosome Diagnostics and Therapeutics Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2019) 4.3 Date of Key Manufacturers Enter into Exosome Diagnostics and Therapeutics Market 4.4 Global Top Players Exosome Diagnostics and Therapeutics Headquarters and Area Served 4.5 Key Players Exosome Diagnostics and Therapeutics Product Solution and Service 4.6 Competitive Status 4.6.1 Exosome Diagnostics and Therapeutics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Aethlon Medical(US) 5.1.1 Aethlon Medical(US) Profile 5.1.2 Aethlon Medical(US) Main Business 5.1.3 Aethlon Medical(US) Products, Services and Solutions 5.1.4 Aethlon Medical(US) Revenue (US$ Million) & (2015-2020) 5.1.5 Aethlon Medical(US) Recent Developments 5.2 Exosome Diagnostics(US) 5.2.1 Exosome Diagnostics(US) Profile 5.2.2 Exosome Diagnostics(US) Main Business and Company’s Total Revenue 5.2.3 Exosome Diagnostics(US) Products, Services and Solutions 5.2.4 Exosome Diagnostics(US) Revenue (US$ Million) (2015-2020) 5.2.5 Exosome Diagnostics(US) Recent Development and Reaction to Covid-19 5.3 NanoSomix Inc.(US) 5.5.1 NanoSomix Inc.(US) Profile 5.3.2 NanoSomix Inc.(US) Main Business 5.3.3 NanoSomix Inc.(US) Products, Services and Solutions 5.3.4 NanoSomix Inc.(US) Revenue (US$ Million) & (2015-2020) 5.3.5 Thermo Fisher Scientific (US) Recent Developments 5.4 Thermo Fisher Scientific (US) 5.4.1 Thermo Fisher Scientific (US) Profile 5.4.2 Thermo Fisher Scientific (US) Main Business 5.4.3 Thermo Fisher Scientific (US) Products, Services and Solutions 5.4.4 Thermo Fisher Scientific (US) Revenue (US$ Million) & (2015-2020) 5.4.5 Thermo Fisher Scientific (US) Recent Developments 5.5 Malvern Instruments (UK) 5.5.1 Malvern Instruments (UK) Profile 5.5.2 Malvern Instruments (UK) Main Business 5.5.3 Malvern Instruments (UK) Products, Services and Solutions 5.5.4 Malvern Instruments (UK) Revenue (US$ Million) & (2015-2020) 5.5.5 Malvern Instruments (UK) Recent Developments 5.6 System Biosciences(US) 5.6.1 System Biosciences(US) Profile 5.6.2 System Biosciences(US) Main Business 5.6.3 System Biosciences(US) Products, Services and Solutions 5.6.4 System Biosciences(US) Revenue (US$ Million) & (2015-2020) 5.6.5 System Biosciences(US) Recent Developments 5.7 NX Pharmagen (US) 5.7.1 NX Pharmagen (US) Profile 5.7.2 NX Pharmagen (US) Main Business and Company’s Total Revenue 5.7.3 NX Pharmagen (US) Products, Services and Solutions 5.7.4 NX Pharmagen (US) Revenue (US$ Million) (2015-2020) 5.7.5 NX Pharmagen (US) Recent Development and Reaction to Covid-19 5.8 Sistemic Inc(UK) 5.8.1 Sistemic Inc(UK) Profile 5.8.2 Sistemic Inc(UK) Main Business 5.8.3 Sistemic Inc(UK) Products, Services and Solutions 5.8.4 Sistemic Inc(UK) Revenue (US$ Million) & (2015-2020) 5.8.5 Sistemic Inc(UK) Recent Developments 5.9 Capricor Therapeutics (US) 5.9.1 Capricor Therapeutics (US) Profile 5.9.2 Capricor Therapeutics (US) Main Business 5.9.3 Capricor Therapeutics (US) Products, Services and Solutions 5.9.4 Capricor Therapeutics (US) Revenue (US$ Million) & (2015-2020) 5.9.5 Capricor Therapeutics (US) Recent Developments 5.10 Exiqon A/S (Denmark) 5.10.1 Exiqon A/S (Denmark) Profile 5.10.2 Exiqon A/S (Denmark) Main Business 5.10.3 Exiqon A/S (Denmark) Products, Services and Solutions 5.10.4 Exiqon A/S (Denmark) Revenue (US$ Million) & (2015-2020) 5.10.5 Exiqon A/S (Denmark) Recent Developments 6 North America 6.1 North America Exosome Diagnostics and Therapeutics Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Exosome Diagnostics and Therapeutics Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Exosome Diagnostics and Therapeutics Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Exosome Diagnostics and Therapeutics Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Exosome Diagnostics and Therapeutics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Exosome Diagnostics and Therapeutics Market Size by Region (2015-2020) (US$ Million) Table 3. Global Exosome Diagnostics and Therapeutics Market Size Share by Region (2015-2020) Table 4. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Exosome Diagnostics and Therapeutics Forecasted Market Size Share by Region (2021-2026) Table 6. Global Exosome Diagnostics and Therapeutics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 8. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2015-2020) Table 9. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2021-2026) Table 11. Global Exosome Diagnostics and Therapeutics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 13. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2015-2020) Table 14. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2021-2026) Table 16. Global Exosome Diagnostics and Therapeutics Revenue (US$ Million) by Players (2015-2020) Table 17. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2019) Table 19. Date of Key Manufacturers Enter into Exosome Diagnostics and Therapeutics Market Table 20. Global Exosome Diagnostics and Therapeutics Top Players Headquarters and Area Served Table 21. Exosome Diagnostics and Therapeutics Product Solution and Service Table 22. Global Exosome Diagnostics and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Aethlon Medical(US) Basic Information List Table 25. Aethlon Medical(US) Description and Business Overview Table 26. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 27. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of Aethlon Medical(US) (2015-2020) Table 28. Aethlon Medical(US) Recent Developments Table 29. Exosome Diagnostics(US) Basic Information List Table 30. Exosome Diagnostics(US) Description and Business Overview Table 31. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 32. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of Exosome Diagnostics(US) (2015-2020) Table 33. Exosome Diagnostics(US) Recent Developments Table 34. NanoSomix Inc.(US) Basic Information List Table 35. NanoSomix Inc.(US) Description and Business Overview Table 36. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 37. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of NanoSomix Inc.(US) (2015-2020) Table 38. NanoSomix Inc.(US) Recent Developments Table 39. Thermo Fisher Scientific (US) Basic Information List Table 40. Thermo Fisher Scientific (US) Description and Business Overview Table 41. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 42. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of Thermo Fisher Scientific (US) (2015-2020) Table 43. Thermo Fisher Scientific (US) Recent Developments Table 44. Malvern Instruments (UK) Basic Information List Table 45. Malvern Instruments (UK) Description and Business Overview Table 46. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 47. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of Malvern Instruments (UK) (2015-2020) Table 48. Malvern Instruments (UK) Recent Developments Table 49. System Biosciences(US) Basic Information List Table 50. System Biosciences(US) Description and Business Overview Table 51. System Biosciences(US) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 52. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of System Biosciences(US) (2015-2020) Table 53. System Biosciences(US) Recent Developments Table 54. NX Pharmagen (US) Basic Information List Table 55. NX Pharmagen (US) Description and Business Overview Table 56. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 57. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of NX Pharmagen (US) (2015-2020) Table 58. NX Pharmagen (US) Recent Developments Table 59. Sistemic Inc(UK) Basic Information List Table 60. Sistemic Inc(UK) Description and Business Overview Table 61. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 62. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of Sistemic Inc(UK) (2015-2020) Table 63. Sistemic Inc(UK) Recent Developments Table 64. Capricor Therapeutics (US) Basic Information List Table 65. Capricor Therapeutics (US) Description and Business Overview Table 66. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 67. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of Capricor Therapeutics (US) (2015-2020) Table 68. Capricor Therapeutics (US) Recent Developments Table 69. Exiqon A/S (Denmark) Basic Information List Table 70. Exiqon A/S (Denmark) Description and Business Overview Table 71. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Products, Services and Solutions Table 72. Revenue (Million US$) in Exosome Diagnostics and Therapeutics Business of Exiqon A/S (Denmark) (2015-2020) Table 73. Exiqon A/S (Denmark) Recent Developments Table 74. North America Exosome Diagnostics and Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 75. North America Exosome Diagnostics and Therapeutics Market Size Share by Country (2015-2020) Table 76. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 77. Europe Exosome Diagnostics and Therapeutics Market Size Share by Country (2015-2020) Table 78. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 79. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size Share by Country (2015-2020) (US$ Million) Table 80. Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 81. Latin America Exosome Diagnostics and Therapeutics Market Size Share by Country (2015-2020) (US$ Million) Table 82. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Players (2015-2020) (US$ Million) Table 83. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Share by Players (2015-2020) (US$ Million) Table 84. Exosome Diagnostics and Therapeutics Market Trends Table 85. Exosome Diagnostics and Therapeutics Market Drivers Table 86. Exosome Diagnostics and Therapeutics Market Challenges Table 87. Exosome Diagnostics and Therapeutics Market Restriants Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Global Exosome Diagnostics and Therapeutics Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Exosome Diagnostics and Therapeutics Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Exosome Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2026 Figure 4. North America Exosome Diagnostics and Therapeutics Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Exosome Diagnostics and Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Exosome Diagnostics and Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Exosome Diagnostics and Therapeutics Market Share by Type in 2020 & 2026 Figure 10. Instrument Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Reagent Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Software Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Global Exosome Diagnostics and Therapeutics Market Size Share by Application in 2020 & 2026 Figure 14. Diagnostic Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Therapeutic Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Top 5 and Top 10 Players Exosome Diagnostics and Therapeutics Market Share in 2019 Figure 18. United States Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Canada Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Germany Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. France Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. U.K. Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Italy Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Russia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Nordic Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Rest of Europe Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. China Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Japan Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. South Korea Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Southeast Asia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. India Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Australia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Rest of Asia-Pacific Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Mexico Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Brazil Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Rest of Latin America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Turkey Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Saudi Arabia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. UAE Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Rest of Middle East & Africa Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Bottom-up and Top-down Approaches for This Report Figure 42. Data Triangulation

Aethlon Medical(US) Exosome Diagnostics(US) NanoSomix Inc.(US) Thermo Fisher Scientific (US) Malvern Instruments (UK) System Biosciences(US) NX Pharmagen (US) Sistemic Inc(UK) Capricor Therapeutics (US) Exiqon A/S (Denmark)